Skip to main content

Genus Capital Management Inc.

Position in MRK — Merck & Co., Inc.

CIK 1532385 VANCOUVER, A1

Position in MRK

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$2,919,391
-$9,468,794 QoQ
Shares Held
22,719
-77.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,356
of 3,769 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$445,570
PutShares
4,479

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names. MRK ranks #6 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 MRK
Merck & Co., Inc.
This page
22,719 $2,919,391

All Filings in MRK

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,919,391 22,719
2026-03-31 $12,388,185 102,986
2025-12-31 $5,836,982 55,453
2025-06-30 $202,174 2,554
2025-03-31 $346,383 3,859
2024-12-31 $445,570 4,479
2024-09-30 $6,653,593 58,591
2024-06-30 $18,739,977 151,373
2024-03-31 $22,378,851 169,601
2023-12-31 $18,970,897 174,013
2023-09-30 $21,046,480 204,434
2023-06-30 $19,223,974 166,600